XML 30 R16.htm IDEA: XBRL DOCUMENT v2.3.0.15
Income Taxes
9 Months Ended
Sep. 30, 2011
Income Taxes [Abstract] 
Income Taxes

Note 10Income Taxes

The deferred tax assets and deferred tax liabilities and related valuation allowance were comprised of the following:

 

     September 30,
2011
    December 31,
2010
 

Deferred tax assets:

    

Net operating losses

   $ 14,765      $ 7,395   

Research and development credits

     3,287        3,063   

Accounts receivable

     170        —     

Inventory

     453        —     

Valuation reserves and accrued liabilities

     10,275        1,699   

Other credits

     820        722   

Property and equipment

     4,849        293   

Intangible assets

     156        —     

Deferred revenue

     —          18   

Other

     2,098        1,032   
  

 

 

   

 

 

 
     36,873        14,222   

Deferred tax liabilities:

    

Intangible assets

     (26,975     (913

Property and equipment

     (229     (202

Accounts receivable

     (214     (322

Valuation reserves and accrued liabilities

     (1,060     —     

Other

     (3,182     (22
  

 

 

   

 

 

 
     (31,660     (1,459

Valuation allowance

     (6,579     (6,579
  

 

 

   

 

 

 

Net deferred tax liability

   $ (1,366   $ 6,184   
  

 

 

   

 

 

 

Reconciliations between the statutory Federal income tax rate of 34% and the effective rate of income tax expense are as follows:

 

     Three Months Ended
September  30,
    Nine Months Ended
September  30,
 
     2011     2010     2011     2010  

Statutory Federal income tax rate

     34.0     34.0     34.0     34.0

Increase (Decrease) resulting from:

        

Effect of different tax rates of foreign jurisdictions

     (15.4 %)      —          (2.4 %)      —     

State and local tax, net of federal benefit

     14.4     4.1     14.8     3.9

Nondeductible acquisition transaction expenses

     —          —          22.0     —     

Other Nondeductible expenses

     9.8     0.8     6.6     0.6

Nondeductible stock option compensation

     0.7     1.8     1.3     1.6

R&D Credits

     (2.6 %)      (3.9 %)      (4.6 %)      (3.4 %) 

Other

     (1.9 %)      —          (0.6 %)      —     
  

 

 

   

 

 

   

 

 

   

 

 

 

Effective rate

     39.0     36.8     71.1     36.7